← Back to all trials
Completed
NCT04383418
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults
Conditions: Preoperative Sedation
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 309
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Location: Zhongshan Hospital Fudan University Shanghai
Summary
The study is being conducted to evaluate the efficacy and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in adults. To explore the reasonable dosage of dexmedetomidine hydrochloride nasal spray for preoperative sedation.
Eligibility Criteria
Inclusion Criteria:
1. Able and willing to provide a written informed consent.
2. Scheduled for elective abdominal surgery (excluding hepatic surgery) under general anesthesia, with an expected operative duration of 1-4 hours.
3. Male or female adults aged between 18 and 65 years,
4. Meet the weight standard:18.5 kg/m²≤BMI≤30 kg/m²
5. Conform to the ASA Physical Status Classification:classification I II.
Exclusion Criteria:
1. Not suitable for nasal spray
2. Having received general anesthesia within 28 days prior to randomization
3. Subjects with a history of myocardial infarction or unstable angina pectoris
4. Subjects with heart rate\
Source: ClinicalTrials.gov (NCT04383418). StuddyBuddy aggregates publicly available trial information.